Home › Biblio

Biblio

Found 10 results

2011
DeZern AE, Sung A, Kim S, Smith DB, Karp JE, Gore SD, Jones RJ, Fuchs E, Luznik L, McDevitt M et al..  2011.  Role of allogeneic transplantation for FLT3/ITD acute myeloid leukemia: outcomes from 133 consecutive newly diagnosed patients from a single institution.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(9):1404-9. Abstract
Bolaños-Meade J, Smith DB, Gore SD, McDevitt MA, Luznik L, Fuchs EJ, Jones RJ.  2011.  5-azacytidine as salvage treatment in relapsed myeloid tumors after allogeneic bone marrow transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(5):754-8. Abstract
2010
Luznik L, Jones RJ, Fuchs EJ.  2010.  High-dose cyclophosphamide for graft-versus-host disease prevention.. Current opinion in hematology. 17(6):493-9. Abstract
Brodsky RA, Chen AR, Dorr D, Fuchs EJ, Huff CA, Luznik L, Smith DB, Matsui WH, Goodman SN, Ambinder RF et al..  2010.  High-dose cyclophosphamide for severe aplastic anemia: long-term follow-up.. Blood. 115(11):2136-41. Abstract
Luznik L, Bolaños-Meade J, Zahurak M, Chen AR, Smith DB, Brodsky R, Huff CA, Borrello I, Matsui W, Powell JD et al..  2010.  High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease.. Blood. 115(16):3224-30. Abstract
Kasamon YL, Luznik L, Leffell MS, Kowalski J, Tsai H-L, Bolaños-Meade J, Morris LE, Crilley PA, O'Donnell PV, Rossiter N et al..  2010.  Nonmyeloablative HLA-haploidentical bone marrow transplantation with high-dose posttransplantation cyclophosphamide: effect of HLA disparity on outcome.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 16(4):482-9. Abstract
2008
Warlick ED, O'Donnell PV, Borowitz M, Grupka N, Decloe L, Garrett-Mayer E, Borrello I, Brodsky R, Fuchs E, Huff CA et al..  2008.  Myeloablative allogeneic bone marrow transplant using T cell depleted allografts followed by post-transplant GM-CSF in high-risk myelodysplastic syndromes.. Leukemia research. 32(9):1439-47. Abstract
Luznik L, O'Donnell PV, Symons HJ, Chen AR, Leffell SM, Zahurak M, Gooley TA, Piantadosi S, Kaup M, Ambinder RF et al..  2008.  HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 14(6):641-50. Abstract
2007
Bolaños-Meade J, Garrett-Mayer E, Luznik L, Anders V, Webb J, Fuchs EJ, Huff CA, Matsui W, Borrello IM, Brodsky R et al..  2007.  Induction of autologous graft-versus-host disease: results of a randomized prospective clinical trial in patients with poor risk lymphoma.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 13(10):1185-91. Abstract
2006
Huff CA, Fuchs EJ, Smith DB, Blackford A, Garrett-Mayer E, Brodsky RA, Flinn IW, Ambinder RF, Borrello IM, Matsui WH et al..  2006.  Graft-versus-host reactions and the effectiveness of donor lymphocyte infusions.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 12(4):414-21. Abstract

Your Support is the Key

Submitted by admin on May 9, 2011 - 11:20am

Matthew Slattery

Help children like Matthew unlock their potential by becoming a Partner in Potential.

Donate Learn More